$2.23T
Total marketcap
$74.1B
Total volume
BTC 56.26%     ETH 9.00%
Dominance
Becton, Dickinson and Company

Becton, Dickinson and Company BDX Stock

$143.92   2.281280%
Add to favorites
Exchange
Market Cap
$39.66B
LOW - HIGH [24H]
$141.25 - $145.59
VOLUME [24H]
$2.15M
P/E Ratio
25.11
Earnings per share
$5.73
ISIN
US0758871091
Price   Prediction

Becton, Dickinson and Company Price Chart

Sorry, that's all we've gotfor now...

Becton, Dickinson and Company BDX Financial and Trading Overview

Becton, Dickinson and Company stock price 143.92 USD
Previous Close 143.98 USD
Open 142.44 USD
Bid 140.12 USD x 50000
Ask 140.18 USD x 50000
Day's Range 140.11 - 143.36 USD
52 Week Range 127.59 - 187.35 USD
Volume 3.38M USD
Avg. Volume 2.8M USD
Market Cap 38.77B USD
Beta (5Y Monthly) 0.278
PE Ratio (TTM) 24.55672
EPS (TTM) 5.73 USD
Forward Dividend & Yield 4.2 (2.91%)
Ex-Dividend Date June 9, 2026
1y Target Est 180.69 USD

BDX Valuation Measures

Enterprise Value 56.14B USD
Trailing P/E 24.55672
Forward P/E 10.508659
PEG Ratio (5 yr expected) 1.11
Price/Sales (ttm) 1.7443333
Price/Book (mrq) 1.606572
Enterprise Value/Revenue 2.526
Enterprise Value/EBITDA 9.117

Trading Information

Becton, Dickinson and Company Stock Price History

Beta (5Y Monthly) 0.278
52-Week Change 7.90%
S&P500 52-Week Change 24.48%
52 Week High 187.35 USD
52 Week Low 127.59 USD
50-Day Moving Average 148.96 USD
200-Day Moving Average 154.07 USD

BDX Share Statistics

Avg. Volume (3 month) 2.8M USD
Avg. Daily Volume (10-Days) 2.4M USD
Shares Outstanding 275.54M
Float 274.74M
Short Ratio 2.14
% Held by Insiders 0.41%
% Held by Institutions 99.30%
Shares Short 7.2M
Short % of Float 2.97%
Short % of Shares Outstanding 2.60%

Dividends & Splits

Trailing Annual Dividend Rate 4.18
Trailing Annual Dividend Yield 2.90%
5 Year Average Dividend Yield 166.00%
Payout Ratio 0.7295
Last Split Factor 1272:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End September 30, 2026

Profitability

Profit Margin 5.12%
Operating Margin (ttm) 14.74%
Gross Margin 47.09%
EBITDA Margin 27.70%

Management Effectiveness

Return on Assets (ttm) 4.38%
Return on Equity (ttm) 6.67%

Income Statement

Revenue (ttm) 22.23B USD
Revenue Per Share (ttm) 77.99 USD
Quarterly Revenue Growth (yoy) 5.20%
Gross Profit (ttm) 10.47B USD
EBITDA 6.16B USD
Net Income Avi to Common (ttm) 1.65B USD
Diluted EPS (ttm) 5.73
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 816M USD
Total Cash Per Share (mrq) 2.96 USD
Total Debt (mrq) 17.28B USD
Total Debt/Equity (mrq) 71.6 USD
Current Ratio (mrq) 0.942
Book Value Per Share (mrq) 87.584

Cash Flow Statement

Operating Cash Flow (ttm) 3.83B USD
Levered Free Cash Flow (ttm) 4.53B USD

Profile of Becton, Dickinson and Company

Country United States
State NJ
City Franklin Lakes
Address 1 Becton Drive
ZIP 07417-1880
Phone 201 847 6800
Website https://www.bd.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 60000

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems. It also offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, and microorganism identification and drug susceptibility, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent system, and solution for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. It provides hernia and soft tissue repair, biological and bioresorbable graft, biosurgery, and other surgical products; surgical infection prevention, peripheral intervention, and urology and critical care products. The company has a strategic collaboration with ChemoGLO for the advancement of hazardous drug contamination testing in health care settings to improve the safety of health care workers. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Q&A For Becton, Dickinson and Company Stock

What is a current BDX stock price?

Becton, Dickinson and Company BDX stock price today per share is 143.92 USD.

How to purchase Becton, Dickinson and Company stock?

You can buy BDX shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Becton, Dickinson and Company?

The stock symbol or ticker of Becton, Dickinson and Company is BDX.

Which industry does the Becton, Dickinson and Company company belong to?

The Becton, Dickinson and Company industry is Medical Instruments & Supplies.

How many shares does Becton, Dickinson and Company have in circulation?

The max supply of Becton, Dickinson and Company shares is 275.54M.

What is Becton, Dickinson and Company Price to Earnings Ratio (PE Ratio)?

Becton, Dickinson and Company PE Ratio is 25.11692800 now.

What was Becton, Dickinson and Company earnings per share over the trailing 12 months (TTM)?

Becton, Dickinson and Company EPS is 5.73 USD over the trailing 12 months.

Which sector does the Becton, Dickinson and Company company belong to?

The Becton, Dickinson and Company sector is Healthcare.

Becton, Dickinson and Company BDX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.symbol }} {{ item.name }} {{ item.symbol }} {{ item.country.toUpperCase() }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
us S&P 500 INDEX SPX US 7365.46 USD
-1.44
3.66B USD 7347.6 USD 7424.17 USD 3.66B USD
us S&P 500 (Yahoo.com) GSPC US 7365.46 USD
-1.44
3.66B USD 7347.6 USD 7424.17 USD 3.66B USD
us US Tech US Broad Dividend Achiev DAA US 4461.52 USD
-0.26
4444.29 USD 4474.67 USD
us NQ US Medical Supplies Large M NQUSB4537LMN US 3087.37 USD
<0.01
3057.02 USD 3124.33 USD
us US Tech Factor Family US Low Vol NQFFUSLV US 1814.91 USD
+1.16
1798.91 USD 1817.69 USD
us US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD US 2100.38 AUD 1467.26 USD
<0.01
2100.38 AUD 1467.26 USD 2100.38 AUD 1467.26 USD
us US Tech US Low Volatility Divide LVDA US 1290.98 USD
+1.3
1279.34 USD 1292.61 USD
us US Tech US Broad Dividend Achiev DAATR US 8363.59 USD
-0.25
8331.29 USD 8388.24 USD
us NYSE Composite Index NYA US 23463.63 USD
-0.56
us NQ US Medical Supplies Lg Md C NQUSB4537LMJPYT US 3149.56 JPY 21.26 USD
<0.01
3149.56 JPY 21.26 USD 3149.56 JPY 21.26 USD
us US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG US 4123.39 USD
-2.34
4089.8 USD 4163.55 USD
us US Tech CRD Global Sustainabilit NQCRD US 1735.62 USD
0
1715.94 USD 1757.95 USD
Select currency